Skip to content
DataLookout
Menu

NCT07905911

Maximum Lysis on Thromboelastography as a Marker of Systemic Severity in Acute Allergic Reactions

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Maximum Lysis by Allergic Reaction Severity
Timeframe: Baseline

Secondary (2)

Hospital Admission
Intensive Care Utilization

Arms and interventions

Diagnostic tests: Thromboelastogram

Sites

1 site in 1 country

  • Mayo ClinicRochester, Minnesota, United States